• Mon espace de travail
  • Aide IRIS
  • Par Publication Par Personne Par Unité
    • English
    • Français
  • Se connecter
Logo du site

IRIS | Système d’Information de la Recherche Institutionnelle

  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
UNIL
  • English
  • Français
Se connecter
IRIS
  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
  • Mon espace de travail
  • Aide IRIS

Parcourir IRIS

  • Par Publication
  • Par Personne
  • Par Unité
  1. Accueil
  2. IRIS
  3. Publication
  4. A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.
 
  • Détails
Titre

A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.

Type
article
Institution
Externe
Périodique
Journal of Proteome Research  
Auteur(s)
Tang, H.Y.
Auteure/Auteur
Beer, L.A.
Auteure/Auteur
Chang-Wong, T.
Auteure/Auteur
Hammond, R.
Auteure/Auteur
Gimotty, P.
Auteure/Auteur
Coukos, G.
Auteure/Auteur
Speicher, D.W.
Auteure/Auteur
Liens vers les personnes
Coukos, George  
ISSN
1535-3907
Statut éditorial
Publié
Date de publication
2012
Volume
11
Numéro
2
Première page
678
Dernière page/numéro d’article
691
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, N.I.H., Extramural Publication Status: ppublish
Résumé
Proteomics discovery of novel cancer serum biomarkers is hindered by the great complexity of serum, patient-to-patient variability, and triggering by the tumor of an acute-phase inflammatory reaction. This host response alters many serum protein levels in cancer patients, but these changes have low specificity as they can be triggered by diverse causes. We addressed these hurdles by utilizing a xenograft mouse model coupled with an in-depth 4-D protein profiling method to identify human proteins in the mouse serum. This strategy ensures that identified putative biomarkers are shed by the tumor, and detection of low-abundance proteins shed by the tumor is enhanced because the mouse blood volume is more than a thousand times smaller than that of a human. Using TOV-112D ovarian tumors, more than 200 human proteins were identified in the mouse serum, including novel candidate biomarkers and proteins previously reported to be elevated in either ovarian tumors or the blood of ovarian cancer patients. Subsequent quantitation of selected putative biomarkers in human sera using label-free multiple reaction monitoring (MRM) mass spectrometry (MS) showed that chloride intracellular channel 1, the mature form of cathepsin D, and peroxiredoxin 6 were elevated significantly in sera from ovarian carcinoma patients.
Sujets

Amino Acid Sequence

Animals

Blood Proteins/analys...

Case-Control Studies

Cathepsin D/blood

Cell Line, Tumor

Chloride Channels/blo...

Chloride Channels/che...

Disease Models, Anima...

Female

Humans

Mice

Molecular Sequence Da...

Neoplasm Proteins/blo...

Ovarian Neoplasms/blo...

Peroxiredoxin VI/bloo...

Proteome/analysis

Proteomics/methods

ROC Curve

Reproducibility of Re...

Sequence Alignment

Species Specificity

Transplantation, Hete...

Tumor Markers, Biolog...

PID Serval
serval:BIB_3D42B1FD337C
DOI
10.1021/pr200603h
PMID
22032327
WOS
000300458300015
Permalien
https://iris.unil.ch/handle/iris/105487
Date de création
2014-10-14T10:43:06.205Z
Date de création dans IRIS
2025-05-20T18:55:37Z
Fichier(s)
En cours de chargement...
Vignette d'image
Nom

BIB_3D42B1FD337C.P001.pdf

Version du manuscrit

preprint

Taille

2.47 MB

Format

Adobe PDF

PID Serval

serval:BIB_3D42B1FD337C.P001

Somme de contrôle

(MD5):cff80ec920cc54a1061a63d38fa19a57

  • Copyright © 2024 UNIL
  • Informations légales